HRMY FCF Yield: current value, 10-year range and year-by-year history
Cash & Leverage
HRMY's fcf yield is higher than 82% of the last 10 years.
FCF Yield History
HRMY FCF Yield by year
Yearly range of HRMY’s fcf yield from 2020 to 2026. Over the full period it ranged from -3.6% to 22.3%, averaging 8.2%.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 14.1% | 17.8% | 22.3% | 14.3% |
| 2025 | 9.3% | 12.8% | 19.5% | 15.8% |
| 2024 | 9.1% | 11.3% | 12.5% | 10.9% |
| 2023 | 4.3% | 7.7% | 14.5% | 8.6% |
| 2022 | 3.2% | 4.4% | 5.7% | 4.6% |
| 2021 | -0.2% | 2.0% | 3.8% | 3.8% |
| 2020 | -3.6% | -2.0% | -0.2% | -0.2% |
Free cash flow generated divided by market capitalisation. Often more reliable than earnings yield because it reflects actual cash — harder to inflate through accounting choices.
Free Cash Flow / Market Cap × 100%Think of it as the "cash earnings yield" on your investment. High FCF yield vs history suggests the market may be undervaluing the company's real cash generation ability.
- FCF can be lumpy year-to-year due to irregular capex or working capital swings. Look at 3–5 year trends, not single-year readings.
- Businesses intentionally reinvesting for growth will show low or negative FCF yield by design — this metric is less useful for high-growth phase companies.
Is HRMY FCF Yield High or Low Right Now?
Harmony Biosciences Holdings, Inc.'s FCF Yield is currently 14.3%, which is historically high relative to its 10-year historical range. The 10-year median FCF Yield for HRMY is approximately 8.4%. See all HRMY valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.